Fundz

Piramal Pharma Solutions and NP2 Partner to Address Cyclophosphamide Shortages.

Sep 30, 2026

Contract Type

partnership

IndiaManufacturingBiotechnologyEnergyRenewable Energy

Description

Piramal Pharma Solutions and NP2 are collaborating to finalize the development phase of the generic cancer drug cyclophosphamide by October. This partnership aims to enhance the manufacturing capacity and simplify the supply chain, ensuring better access to this essential oncology medicine for patients in the U.S.

Company Information

Company

Piramal Pharma Limited

Location

India

About

Piramal Pharma Limited is a significant player in the pharmaceutical industry, focused on manufacturing active pharmaceutical ingredients and intermediates. The company is committed to sustainability and has set ambitious carbon emission targets, aiming to reduce greenhouse gas emissions. Their recent shifts towards renewable energy sources, like biomass briquettes, reflect their dedication to environmentally responsible manufacturing practices.

Related People

Rory
Senior decision-maker at this company
••••••••@••••••••

See Rory's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Piramal Pharma Limited's next move

Learn about Strategic plan

Agreement Insights

What this usually means
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies

Piramal Pharma Limited signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.